Corvus Pharmaceuticals, Inc. (CRVS) Discusses Phase 1 Clinical Trial Results of Soquelitinib in Atopic Dermatitis with Focus on Cohort 4 - Slideshow (NASDAQ:CRVS) 2026-01-27
Corvus PharmaceuticalsCorvus Pharmaceuticals(US:CRVS) Seeking Alpha·2026-01-27 23:02

Group 1 - The article does not provide any relevant content regarding the company or industry [1]

Corvus Pharmaceuticals, Inc. (CRVS) Discusses Phase 1 Clinical Trial Results of Soquelitinib in Atopic Dermatitis with Focus on Cohort 4 - Slideshow (NASDAQ:CRVS) 2026-01-27 - Reportify